G1SK34:BVMF
Gsk Plc Bdr
R$48.55
0.00%
(0.00) 1D
Oct 15, 9:31:49 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for G1SK34...
Mkt. cap
99.22B
Avg. vol.
221.00
Volume
0.00
52-wk high
R$63.24
52-wk low
R$46.15
Shares outstanding
4.32B
No. of employees
67K
Mkt. cap
99.22B
Avg. vol.
221.00
Volume
0.00
52-wk high
R$63.24
52-wk low
R$46.15
Shares outstanding
4.32B
No. of employees
67K
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
Better Dividend Stock: Pfizer vs. GSK
Stock Titan
·
11 hours ago
Three executives acquire GSK (NYSE: GSK) depositary shares at $46.95 each.
Traders Union
·
14 hours ago
GSK shares gain almost 2% after CEO and CFO increase holdings and technical momentum builds
Dealroom
·
1 day ago
GSK to invest $800M in Pennsylvania, adding 300 jobs
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Gsk Plc Bdr
CEOEmma Walmsley | Emma Walmsley
Employees66.8K
FoundedDec 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com